Treatment of IgA Nephropathy According to Renal Lesions
Status:
Recruiting
Trial end date:
2022-02-20
Target enrollment:
Participant gender:
Summary
TIGER study (Treatment of IgA nEphropathy according to Renal lesions) is a prospective openly
randomized controlled study.
The main objective is to evaluate the efficacy of early corticotherapy + RAS blockade (versus
RAS blockade alone) after two years of evolution in IgAN patients with severe histological
lesions The study will include 122 IgAN patients, it is scheduled to start in september 2017.